Skip to main content

Decision aids in serious illness: dissemination strategy, anyone?

An example decision aid in serious illness: Prepare,

by: Alex Smith, @AlexSmithMD

I was fortunate to be part of a really nice systematic review of decision aids for patients with serious illness by Adrian Austin (senior author Laura Hanson).  This manuscript was published online ahead of print in JAMA: Internal Medicine last week.

For this study, Austin reviewed nearly 10,000 titles to identify 38 rigorous studies that meet inclusion criteria.  Seventeen were randomized controlled trials.

I'm not going to summarize the article here - suffice it to say there are a number of very promising decision aids to help people with serious illness.  The article is self explanatory, and I highly recommend that people at a minimum look at the tables to see if there are decision aids you might like to incorporate into your practice. Note, you have to be a JAMA: Internal Medicine subscriber to read the article.

I'd like to pose a question, raised in part by James Tulsky in his terrific accompanying editorial.  James says:
Hospitals and health care systems must make the commitment to introduce such tools at the point of care to ensure that patients facing decisions have the resources they need when they need them. Most of the tools reviewed by Austin et al are free and could be disseminated relatively inexpensively.
Emailing with Laura Hanson and Rebecca Sudore after the paper was accepted, we were at a loss as to what the next steps should be for dissemination.  In many ways, we are at a similar point to where we were after conducting a systematic review of prognostic indices for older adults.  We decided (spurred by Lindsey Yourman) to put the prognostic indices in our review online - voila!  ePrognosis.

But these decision aid tools differ from prognostic indices in important respects. Several include booklets.  While many are free, others are proprietary videos that must be purchased.  A few do not appear to be publicly available at all.  These are not as amenable to a website compendium or toolkit, like ePrognosis.

The problem is that busy clinicians will not use these tools unless they are easily available.   Putting them in one place, or linking them somehow, makes a tremendous amount of sense.

So my question for you - does anyone have a dissemination strategy for decision aids in serious illness?


Kquotes Com said…
very nice blog post.
Joshua Uy said…
Here are some random thoughts
Direct to consumer advertising w/access to an online warehouse (like
Make it a mandatory reporting requirement like BB for CHF or asa for MI, and then report it
Give people $ off their copays if they use one
Give docs extra money if they use one (i.e. give it it's own CPT code like vaccine administration but decision aid administration) or penalizing it's use
Make it a requirement for specific procedures like a palliative consult before LVAD's.

Popular posts from this blog

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Dying without Dialysis

There is a terrific article in this weeks Journal of Pain and Symptom Management by Fliss Murtagh of King's College in London about the epidemiology of symptoms for patients with advanced renal failure who die without dialysis.  This study is important because while we know that patients with advanced renal failure have a limited life expectancy and the average age of initiation of hemodialysis is increasing, we know little about the alternatives to hemodialysis.  Specifically, we know nothing about symptoms affecting quality of life among patients who elect not to start dialysis (so called "conservative management" - is this the best label?).  This article provides a terrific counterpoint to the article in last years NEJM showing that nursing home residents who initiated hemodialysis tended to die and decline in function (see GeriPal write up here). 

The study authors followed patients with the most advanced form of chronic kidney disease (the new name for renal failu…

Survival from severe sepsis: The infection is cured but all is not well

Severe sepsis is a syndrome marked by a severe infection that results in the failure of at least one major organ system: For example, pneumonia complicated by kidney failure. It is the most common non-cardiac cause of critical illness and is associated with a high mortality rate.

But what happens to those who survive their hospitalization for severe sepsis? An important study published in JAMA from Iwashyna and colleagues provides answers and tells us all is not well. When the patient leaves the hospital, the infection may be cured, but the patient and family will need to contend with a host of major new functional and cognitive deficits.

Iwashyna examined disability and cognitive outcomes among 516 survivors of severe sepsis. These subjects were Medicare enrollees who were participants in the Health and Retirement Study. The average age of patients was 77 years.

When interviewed after discharge, most survivors were left with major new deficits in their ability to live independently. …